CuroniQ AI Labs

The Architecture
of Intuition.

We are building the first infrastructure that turns clinical decision-making into scalable intelligence.

Vision

CuroniQ AI Labs – The Architecture of Intuition

CuroniQ
Request a Private Briefing

Section 02

The Problem

Continuous Medical Education sits at the core of modern healthcare.

Yet despite billions invested in knowledge and training, a fundamental gap remains:

Medical knowledge is expanding exponentially – but real-world medical decisions remain inconsistent.

At the point of care, clinicians operate under uncertainty, time pressure, and cognitive limits.

The result: A persistent gap between what is known – and what is done.

We call this the Knowledge-Decision Gap.

Knowledge-Decision Gap: Causal Chain Exponential Knowledge Growth Studies, guidelines, therapies Limited Cognitive Capacity of the individual clinician Knowledge-Decision Gap Systemic Problem Deviations from Guidelines in Practice Decisions Under Time Pressure & Uncertainty Quality & Efficiency Loss Previous Approaches (Conferences, CME) More information, more content = wrong lever Curoniq Approach Capture and understand decision processes

Section 03

The Breakthrough

The problem is not access to knowledge.

It is the absence of visibility into how decisions are actually made.

Curoniq captures real clinical decision pathways – not just outcomes.

By mapping how clinicians move from information to action, we reveal where evidence translates into practice – and where it breaks down.

This transforms medical education into a system that learns from decision-making itself.

Section 04

The System

At the core of Curoniq is a closed-loop intelligence system embedded within medical education.

Clinicians engage in structured, case-based environments that replicate real-world complexity.

As decisions are made, our system captures behavioral patterns, cognitive pathways, and deviations from evidence-based standards.

Every interaction generates new data.

Over time, this creates a compounding intelligence asset – a proprietary dataset of how clinical decisions are actually made.

The more the system is used, the more valuable it becomes.

Closed-Loop System: Medical Decision Trainer Clinicians Work Through Cases Structured Scenarios Capture Decision Pathways Hypothesis to therapy choice Match Against Evidence Guidelines and current studies Individual Feedback Patterns and blind spots Collective Intelligence Aggregation and scenario improvement Flywheel Effect Proprietary Dataset Scalable Asset-light Hard to replicate Grows with every interaction

Section 05

Market & Invitation

We enter through Continuous Medical Education.

Pharmaceutical companies already invest billions annually into physician education – with limited visibility into real-world impact.

Curoniq addresses both sides of this equation.

We transform existing education budgets into measurable intelligence – while converting information overload into structured, decision-relevant insight.

We are at the beginning of a new intelligence layer in healthcare.

Revenue Model & Competitive Positioning REVENUE STREAMS Indication-Specific Programs (B2B Pharma) SaaS License Hospitals, medical societies Data Insights Anonymized behavioral analytics Proprietary Dataset Clinical Decision Logic COMPETITIVE POSITIONING PASSIVE ACTIVE STATIC ← → LEARNING Traditional CME Passive knowledge transfer Amboss Static reference tool CDS Systems Rule-based recommendations Curoniq Learning system from real behavior Moat Architecture Proprietary behavioral data | Network effect | First-mover Dataset grows with every interaction and is not replicable
Go-to-Market Strategy: Four Phases Phase 1 Stealth / Investors Abstract website Pitchdeck for VCs Evaluate crowdinvesting Private Briefing CTA CURRENT Phase 2 Pilot Pharma pilot partners Critical mass of clinicians Validate closed-loop MDT product page CRITICAL MILESTONE Phase 3 DACH Scale-up Broad DACH scaling Pharma expansion Community building KOL integration Phase 4 International France, Spain Existing contacts EU CME systems Global platform FUNDING REQUIREMENT: 18 MONTHS Product Development MDT to market readiness Pilot Partnerships First pharma partners Critical Mass Initial user base DACH Foundation Scale-up preparation

We invite a small number of partners to join us at its inception.

Thank you.

Your email client should have opened with the briefing request. If not, please contact us directly at info@curoniq.com.